Home

Procter & Gamble Health Ltd PE Ratio

Image

Procter & Gamble Health Ltd

NSE: PGHL

PE

34.3

Last updated on: Apr 28, 2025

Key Highlights

  • The P/E Ratio of Procter & Gamble Health Ltd is 34.3 as of 28 Apr 15:06 PM .
  • The p/e ratio of Procter & Gamble Health Ltd changed from 39.9 to 41.7 over 5 quarters. This represents a CAGR of 3.59% .
  • The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5089 as of 28 Apr 14:57 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Procter & Gamble Health Ltd

No data available

Company Fundamentals for Procter & Gamble Health Ltd

Image

Procter & Gamble Health Ltd

NSE: PGHL

Share Price

₹ 5089.2

14.95 (0.29%)

stock direction

Last updated on: Apr 28, 2025

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Apr 20255074.25
24 Apr 20255225.75
23 Apr 20255248.95
22 Apr 20255164.6
21 Apr 20255236.2
17 Apr 20255229.25
16 Apr 20255223.15
15 Apr 20255220.5
11 Apr 20255167.35
09 Apr 20255216.7

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Procter & Gamble Health Ltd

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Procter & Gamble Health Ltd8422
Sun Pharmaceutical Industries Ltd428725
Divis Laboratories Ltd159525
Cipla Ltd123202
Torrent Pharmaceuticals Ltd109514
Mankind Pharma Ltd105276

PE Ratio of Procter & Gamble Health Ltd Explained

8422

Market cap

236

Earnings

34.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Procter & Gamble Health Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Procter & Gamble Health Ltd

No data available

* All values are in %

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
  • The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The company offers prescription drugs, biotechnology products, and consumer health products, including over-the-counter products.
  • They also offer products for the treatment of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases, and other conditions with unmet medical needs. The company operates in two business divisions, namely Pharmaceuticals and Chemicals.
  • The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products.

Procter & Gamble Health Ltd News Hub

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, owing to c

Read more

22 Aug 24

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on

Read more

21 Aug 24

Procter & Gamble Health to pay final dividend

Procter & Gamble Health announced that final dividend of Rs 60 per share for FY 2024 will be paid by

Read more

21 Aug 24

Broader market outperforms; European mkt opens higher

The headline equity indices traded with decent gains in afternoon trade. The Nifty hovered above the

Read more

22 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Procter & Gamble Health Ltd

What is the current PE Ratio of Procter & Gamble Health Ltd?

The Current PE Ratio of Procter & Gamble Health Ltd is 34.32 as on 28 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 39.9 as on 28 Apr 2025.

What was the PE Ratio of Procter & Gamble Health Ltd last year?

The PE Ratio of Procter & Gamble Health Ltd was 37.97 last year, now the PE ratio is 34.32, showing a year-on-year growth of -9.6%.

What does the PE Ratio of Procter & Gamble Health Ltd indicate about its stock?

The PE Ratio of Procter & Gamble Health Ltd is 34.32. This ratio indicates that investors are willing to pay 34.32 times the earnings per share for each share of Procter & Gamble Health Ltd.

What is the PE Ratio Growth of Procter & Gamble Health Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Procter & Gamble Health Ltd grew by -9.6% whereas, the EPS ratio grew by 10.4.

How does the PE ratio of Procter & Gamble Health Ltd compare to industry peers?

The PE ratio of Procter & Gamble Health Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Procter & Gamble Health Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Procter & Gamble Health Ltd PE Ratio.

What factors influence the PE ratio of Procter & Gamble Health Ltd PE Ratio?

The PE ratio of Procter & Gamble Health Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Procter & Gamble Health Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Procter & Gamble Health Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Procter & Gamble Health Ltd PE Ratio?

You can check the latest PE ratio of Procter & Gamble Health Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Procter & Gamble Health Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Procter & Gamble Health Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Procter & Gamble Health Ltd PE Ratio predict future stock performance?

While the Procter & Gamble Health Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions